ASO Visual Abstract: KRAS and TP53 Circulating Tumor DNA are Prognostic in Localized Pancreatic Cancer
Findings support next-generation sequencing-based ctDNA as a prognostic biomarker to refine risk stratification in patients undergoing neoadjuvant therapy.